|
|
||||||||
1Laboratoire de bactériologie, faculté de pharmacie, 15, avenue Charles Flahault, 34093 Montpellier Cedex 5, France 2Laboratoire de bactériologie, hôpital Arnaud de Villeneuve, 34295 Montpellier Cedex 5, France 3Laboratoire de bactériologie, hôpital Carremeau, 30060 îmes, France
Correspondence Estelle Jumas-Bilak ebilak{at}univ-montp1.fr
Received April 10, 2005
Accepted July 6, 2005
Among the six species characterized within the genus Ochrobactrum, Ochrobactrum anthropi and Ochrobactrum intermedium are currently reported as opportunistic pathogens in humans. Since the species identification is mainly based on 16S rDNA analysis, the aim of this study was to search for other characteristics useful for Ochrobactrum species discrimination. Ribotyping, morphological and biochemical analyses, and antimicrobial susceptibility testing were performed for a panel of 35 clinical isolates, first identified to the species level using 16S rDNA sequencing. Type and reference strains of five Ochrobactrum species were comparatively analysed. Commercial identification systems such as API 20NE and VITEK 2 were tested for their ability to identify Ochrobactrum anthropi and to detect other members of the genus Ochrobactrum. An improved protocol for the identification of Ochrobactrum spp. by routine medical microbiology practices is proposed: isolation of a non-fastidious non-fermenting oxidase-positive Gram-negative rod resistant to all ß-lactams except imipenem indicates the genus Ochrobactrum, and the API 20NE system confirms the genus identification for most strains, whereas the VITEK 2 system using ID-GNB cards was less powerful. Urease activity, the mucoidy of the colonies, growth at 45 °C on tryptic soy agar, and susceptibility to colistin, tobramycin and netilmicin should be considered as differential characteristics for identification of O. anthropi and O. intermedium to the species level. However, definitive identification depends on genotyping methods.
The GenBank/EMBL/DDBJ accession numbers for the 16s rDNA sequences reported in this paper are AF526518AF526526, AY917104AY917119 and AY918295AY918296.
This article has been cited by other articles:
![]() |
C. M. Shilton, G. P. Brown, S. Benedict, and R. Shine Spinal Arthropathy Associated with Ochrobactrum anthropi in Free-ranging Cane Toads (Chaunus [Bufo] marinus) in Australia Vet. Pathol., January 1, 2008; 45(1): 85 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Scholz, M. Pfeffer, A. Witte, H. Neubauer, S. Al Dahouk, U. Wernery, and H. Tomaso Specific detection and differentiation of Ochrobactrum anthropi, Ochrobactrum intermedium and Brucella spp. by a multi-primer PCR that targets the recA gene J. Med. Microbiol., January 1, 2008; 57(1): 64 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kampfer, D. M. Citron, E. J. C. Goldstein, and H. C. Scholz Difficulty in the identification and differentiation of clinically relevant Ochrobactrum species J. Med. Microbiol., November 1, 2007; 56(11): 1571 - 1573. [Full Text] [PDF] |
||||
![]() |
C. Teyssier, H. Marchandin, H. Jean-Pierre, A. Masnou, G. Dusart, and E. Jumas-Bilak Ochrobactrum pseudintermedium sp. nov., a novel member of the family Brucellaceae, isolated from human clinical samples Int J Syst Evol Microbiol, May 1, 2007; 57(5): 1007 - 1013. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |